New clues for predicting rare brain infection linked to MS drugPublished: 05 October 2021 A new study has found that John Cunningham virus mutations may be an early predictor for brain infection in people receiving Tysabri for multiple sclerosis (MS).  Tysabri works by preventing immune cells from entering the brain